Aurobindo Pharma Limited (AUROPHARMA.NS)
NSE - NSE Real Time Price. Currency in INR
Add to watchlist
At close: 03:30PM IST
Currency in INR
Valuation Measures4
| Market Cap (intraday) | 727.48B |
| Enterprise Value | 728.04B |
| Trailing P/E | 22.95 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.54 |
| Price/Book (mrq) | 2.44 |
| Enterprise Value/Revenue | 2.54 |
| Enterprise Value/EBITDA | 11.76 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.51 |
| 52-Week Change 3 | 77.82% |
| S&P500 52-Week Change 3 | 25.87% |
| 52 Week High 3 | 1,292.10 |
| 52 Week Low 3 | 665.75 |
| 50-Day Moving Average 3 | 1,179.98 |
| 200-Day Moving Average 3 | 1,056.14 |
Share Statistics
| Avg Vol (3 month) 3 | 1.62M |
| Avg Vol (10 day) 3 | 1.56M |
| Shares Outstanding 5 | 585.17M |
| Implied Shares Outstanding 6 | 595.23M |
| Float 8 | 280.83M |
| % Held by Insiders 1 | 52.03% |
| % Held by Institutions 1 | 32.32% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 4.5 |
| Forward Annual Dividend Yield 4 | 0.36% |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | 0.69 |
| Payout Ratio 4 | 8.31% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Feb 20, 2024 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jul 20, 2015 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Mar 31, 2024 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 10.94% |
| Operating Margin (ttm) | 17.58% |
Management Effectiveness
| Return on Assets (ttm) | 6.36% |
| Return on Equity (ttm) | 11.18% |
Income Statement
| Revenue (ttm) | 290.02B |
| Revenue Per Share (ttm) | 495.04 |
| Quarterly Revenue Growth (yoy) | 17.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | 58.43B |
| Net Income Avi to Common (ttm) | 31.73B |
| Diluted EPS (ttm) | 54.20 |
| Quarterly Earnings Growth (yoy) | 79.50% |
Balance Sheet
| Total Cash (mrq) | 63.29B |
| Total Cash Per Share (mrq) | 108.02 |
| Total Debt (mrq) | 66.48B |
| Total Debt/Equity (mrq) | 22.27% |
| Current Ratio (mrq) | 1.98 |
| Book Value Per Share (mrq) | 509.34 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 24.35B |
| Levered Free Cash Flow (ttm) | -12.93B |
© 2024 Yahoo. All rights reserved.